Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 496 participants.
Also called NCT02700945
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 496 participants
- Registry
-
NCT02700945
-
- Other papers using this trial's data
- Effect of Long-term Continuous Cardiac Monitoring vs Usual Care on Detection of Atrial Fibrillation in Patients With Stroke Attributed to Large- or Small-Vessel Disease: The STROKE-AF Randomized Clinical Trial
- Predictors of Atrial Fibrillation in Patients With Stroke Attributed to Large- or Small-Vessel Disease: A Prespecified Secondary Analysis of the STROKE AF Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02700945. Randomized; no masking; primary purpose diagnostic. Start 2016-03 (actual); primary completion 2020-08-03 (actual). Results posted on 2021-11-09.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin
- Condition
- Stroke, Acute
- Intervention (Device)
- Reveal LINQ™ Insertable Cardiac Monitor
- Lead sponsor
- Medtronic Cardiac Rhythm and Heart Failure
Record details
- Record id
cardio:ct-nct02700945- Content hash
9e16d9a29c19f5866a56bff7c766d38e02bdb4eb45457c64a5b1b515653e30eb